期刊文献+

隆突性皮肤纤维肉瘤病理诊断及预后的探讨 被引量:4

Pathological diagnosis and prognosis of dermatofibrosarcoma protuberans
暂未订购
导出
摘要 目的 探讨隆突性皮肤纤维肉瘤 (DFSP)的病理诊断及临床病理参数、增殖细胞核抗原 (PCNA)表达与预后的关系。方法 应用免疫组化方法对 5 1例隆突性皮肤纤维肉瘤CD34、PCNA的表达进行检测 ,并结合病理形态学观察和随访分析。结果 所有DFSP均表达CD34。组织分级、浸润深度、局部切除范围与DFSP复发率显著相关。PCNA计数标记指数平均为 4 1 7% ,PCNA高表达组复发率显著高于PCNA低表达组。结论 CD34可作为DFSP与纤维肉瘤特异的鉴别诊断指标。组织分级、浸润深度及PCNA表达可作为判断DFSP预后的指标。 Objective To investigate the differential diagnosis and effective prognostic indicators of dermatofibrosarcoma protuberans (DFSP) and to explore the relationship between the PCNA expression and local recurrence of the tumor. Methods Fifty-one cases of DFSP were investigated. The histopathologic changes were observed and the expression of PCNA and CD34 was detected in all the tumors with an immunohistochemical staining. Results All the tumors expressed CD34. The histologic grading, infiltrative depth and local excision ranges were significantly related to local recurrence of the tumor (p<0.01). The mean PCNA labeling index (LI) of DFSP was 41.7%. The rate of local recurrence was significantly higher in the tumor with the high LI than in the one with low LI (p<0.01). Conclusions CD34 expression can be regarded as an independent indicator for the differential diagnosis between DFSP and fibrosarcoma. The histologic grading, infiltrative depth and PCNA expression can act as effective indicators for prognosis of the patients. The rate of local recurrence is lower in the tumor treated by wide local excision.
出处 《诊断病理学杂志》 CSCD 2002年第1期29-31,T007,共4页 Chinese Journal of Diagnostic Pathology
关键词 隆突性皮肤纤维肉瘤 病理诊断 复发 预后 免疫组织化学 DFSP Dermatofibrosarcoma protuberans Diagnosis Recurrence Prognosis Immunohistochemistry
  • 相关文献

参考文献8

二级参考文献15

  • 1杨小玲,毛永荣,王慧君.隆突性皮纤维肉瘤临床病理及电镜研究[J].中华实验外科杂志,1996,13(6):327-328. 被引量:1
  • 2施渝升 叶庆福.皮肤隆突性纤维肉瘤16例报告[J].中华外科杂志,1995,33(7):421-421.
  • 3黄杰雄,癌症,1996年,15卷,102页
  • 4王亚农,中华肿瘤杂志,1995年,17卷,183页
  • 5姚榛祥,实用肿瘤杂志,1994年,9卷,13页
  • 6丁华野,中国肿瘤临床,1994年,21卷,338页
  • 7王德延,肿瘤病理诊断,1987年,735页
  • 8陈忠年,实用外科病理学,1997年,81页
  • 9施渝升,中华外科杂志,1995年,33卷,7期,421页
  • 101,Libow LF,Eyman CM,Rapp U.Dermatofibrosarcomaprotuberans in an infant with a history of choroid plexus papilloma.Cutis 1999;63(2):95~97

共引文献20

同被引文献24

  • 1段光杰,阎晓初,郭德玉.临床病理学专业本科生实习带教探讨[J].西北医学教育,2004(6):550-551. 被引量:5
  • 2叶秀峰,米粲.提高病理进修生教学质量的探讨[J].山西医科大学学报(基础医学教育版),2005,7(3):241-243. 被引量:3
  • 3[2]Mentzel T,Beham A,Katenkamp D ,et al. Fibrosarcomatous (high grade) dermatotibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance [J]. Am J Surg Pathol, 1998,22 (5):576.
  • 4[3]Soundak V K,Clmmino L M, et al. Dermatofibrosarcoma protuberans :what is the best surgical approach [J]. Surg Oncol, 1999.8(2) :183.
  • 5[6]Harvel J D,Kilpatrick S E,Whi te W L. Hislogonenet ic relations between giant cell fibroblastoma and dermatofibrsacoma protuberahs,CD34 staining the spectra and a strnalater[J]. AMJ Demnatopathol, 1988,20:339.
  • 6[7]Vita V T, Hellman S Jr. Rosenberg S A. Cancer-Principles and Practice 0fOncolO书[M].5th Edition.济南:山东科学技术出版社,2001.1814.
  • 7周叔恭,魏武,杨小玲.隆突性皮肤纤维肉瘤143例治疗体会[J].中国肿瘤临床,1999,26(增刊):160.
  • 8[9]Hobbs E R,Wheeland R G, Bailin P L,et al. Treatment of dermatofibrosarcomas protuberans with Mohs micrographic surgery[J].Ann Surg, 1988,207:102 - 107.
  • 9[10]Ballo M T, Zagars G K, Pisters P, et al. The role of radistion therapy in the management of dermatofibrosarcomas protuberans [J]. Int J Radiat Oncol Biol phys, 1998,40 (4) :823 -827.
  • 10[11]Sun L M,Wang C J,HuangCC ,et al. Dematofibroesrecomas protuberans: treatment of 35 cases[J]. Radiotherapy and oncology,2000,57:175 - 181.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部